- Home
- JBLU vs RCKT Comparison
JBLU vs RCKT Comparison
Compare JBLU & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- RCKT
- Stock Information
- Founded
- JBLU 1998
- RCKT 1999
- Country
- JBLU United States
- RCKT United States
- Employees
- JBLU N/A
- RCKT N/A
- Industry
- JBLU Air Freight/Delivery Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- JBLU Consumer Discretionary
- RCKT Health Care
- Exchange
- JBLU Nasdaq
- RCKT Nasdaq
- Market Cap
- JBLU 2.0B
- RCKT 1.9B
- IPO Year
- JBLU N/A
- RCKT N/A
- Fundamental
- Price
- JBLU $5.67
- RCKT $17.13
- Analyst Decision
- JBLU Hold
- RCKT Strong Buy
- Analyst Count
- JBLU 10
- RCKT 9
- Target Price
- JBLU $6.31
- RCKT $53.22
- AVG Volume (30 Days)
- JBLU 17.0M
- RCKT 731.3K
- Earning Date
- JBLU 10-29-2024
- RCKT 11-04-2024
- Dividend Yield
- JBLU N/A
- RCKT N/A
- EPS Growth
- JBLU N/A
- RCKT N/A
- EPS
- JBLU N/A
- RCKT N/A
- Revenue
- JBLU $9,327,000,000.00
- RCKT N/A
- Revenue This Year
- JBLU N/A
- RCKT N/A
- Revenue Next Year
- JBLU $4.68
- RCKT $300.20
- P/E Ratio
- JBLU N/A
- RCKT N/A
- Revenue Growth
- JBLU N/A
- RCKT N/A
- 52 Week Low
- JBLU $3.42
- RCKT $15.98
- 52 Week High
- JBLU $8.07
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- JBLU 38.78
- RCKT 46.41
- Support Level
- JBLU $6.86
- RCKT $17.05
- Resistance Level
- JBLU $7.49
- RCKT $17.75
- Average True Range (ATR)
- JBLU 0.37
- RCKT 0.72
- MACD
- JBLU -0.18
- RCKT 0.06
- Stochastic Oscillator
- JBLU 0.46
- RCKT 40.23
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.